English Overview
- Introduction to Dyslipidemia Burden & Gaps
- LDL-C Reduction Guidelines and Targets
- Use of PCSK9i in Very High Risk Patients with Diabetes
This Activity for
- Resident / Fellow
- Physician
What I will learn?
By the end of the activity, participants will be able to apply the latest dyslipidemia treatment guidelines to at least 90% of their patients, as demonstrated by post-activity quizzes or case study discussions.
By the end of the activity, 85% of participants will demonstrate the ability to identify high-risk patients for dyslipidemia-related cardiovascular events using lipid panel results and patient history during a case-based discussion.
Within one month of completing the activity, participants will report at least a 20% improvement in their ability to communicate the benefits and risks of dyslipidemia treatment to patients, as measured by follow-up surveys.
By the end of the activity, participants will be able to design a comprehensive treatment plan, incorporating both pharmacological and non-pharmacological interventions, for at least 80% of the case studies provided.
By the end of the activity, 85% of participants will demonstrate the ability to identify high-risk patients for dyslipidemia-related cardiovascular events using lipid panel results and patient history during a case-based discussion.
Within one month of completing the activity, participants will report at least a 20% improvement in their ability to communicate the benefits and risks of dyslipidemia treatment to patients, as measured by follow-up surveys.
By the end of the activity, participants will be able to design a comprehensive treatment plan, incorporating both pharmacological and non-pharmacological interventions, for at least 80% of the case studies provided.
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
|
SmartCare Dyslipidemia: Prevent the 1st Event Certificate
Accreditation |
Certificate | Free |
VAT 15% Included
